Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BAXTER INTERNATIONAL INC Director's Dealing 2021

Jun 24, 2021

30537_dirs_2021-06-23_2bb0dee3-4796-4425-813c-fbc594d54eda.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Miromatrix Medical Inc. (MIRO)
CIK: 0001527096
Period of Report: 2021-06-23

Reporting Person: BAXTER INTERNATIONAL INC (10% Owner)
Reporting Person: BAXTER HEALTHCARE CORP (10% Owner)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Series C Convertible Preferred Stock $ Common Stock (2343750) Indirect

Footnotes

F1: The Series C Convertible Preferred Stock is convertible into the number of shares of the Issuer's common stock shown in column 3 and have no expiration date. The Series C Convertible Preferred Stock will automatically convert into common stock upon the closing of the Issuer's initial public offering.

F2: The reported securities are owned directly by Baxter Healthcare Corporation, a wholly owned subsidiary of Baxter International Inc.